hsa-mir-6844 _LIHC.png
TAF2 _LIHC.png
Expression analysis of TCGA samples
Basic Information
VIS ID
TVIS10011645
Fusion event
HBV-TAF2 integration
Validated
No
Detection method
NGS
Data source
Curated
Sample type
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Reported year
2018
PubMed ID
Virus Sequence
Virus name
HBV
Reference genome
Region type
precore/core protein|Core and e antigen|
Start
2062
Orient
+
Integrated sequence
TCTGACTTCTTTCCTTCAGTACGAGATCTTCTAGATACCGCCTCAGCTCTGTATCGGGAAGCCTTAGAGTCTCCTGAGCATTGTTCACCTCACCATACTG| |CACTCAGGCAAGCAATTCTTTGCTGGGGGGAACTAATGACTCTAGCTACCTGGGTGGGTGTTAATTTGGAAGATCCAGCGTCTAGAGACCTAGTAGTCAG
Host Sequence
Chromosome
chr8
Cytoband
q24.12
Reference genome
End
120839223/119826983 (Hg38)
Orient
-
Location type
Intronic
Fragile sites / regions
Target gene
Nearest miRNA
hsa-mir-12123/Upstream/501718; hsa-mir-10400/Downstream/3388805;
Upstream sequence
ttttctgggagtttaatcctaaggaaaaccaaggatatacagagaagtatatttataaagctaatcttattgacttgttaaagctcaaaattggcagcaa
Downstream sequence
aggagtttgagaccagcctaagcaacatggcaaaactccgtctctacaaaaaatacaaaaattagccaggctggtggtacgtgcctgtggtcccagctac
Reference
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.
Curate